Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
de Heer EC., Zois CE., Bridges E., van der Vegt B., Sheldon H., Veldman WA., Zwager MC., van der Sluis T., Haider S., Morita T., Baba O., Schröder CP., de Jong S., Harris AL., Jalving M.